HANOVER, Germany--(BUSINESS WIRE)--Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced ...

About 70 percent of our genes provide the blueprint for biomolecules whose function is only now being discovered – non-coding RNAs. Instead of being translated into proteins, they seem to perform ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Cardiologists’ and radiologists’ efforts to receive proper reimbursement for cardiac computed ...

Find the Atomic Heart VDNH door code by searching the blackboard in the office opposite the combination lock door and you can get a loot chest for your efforts. If you've made it to the VDNH, you'll ...

Novo Nordisk is adding on to its cardiovascular drug pipeline with the acquisition of Cardior Pharmaceuticals, a genetic medicines developer whose lead program is in mid-stage clinical testing in ...